
Thursday, May 30, 2013 (11:00 a.m. – 1:00 p.m.) PhRMA Boardroom 950 F Street, Suite 300, Washington, D.C. Dial In: 1-800-875-3456 Verbal Passcode: VC20743 “Advancing Patient-Focused Drug Development and Benefit-Risk Assessment” We are pleased to announce the first in a series of informational briefings for stakeholders [...]







